Seven Eight Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-45,494
| Closed | -$853K | – | 879 |
|
|
2024
Q1 | $853K | Buy |
45,494
+24,610
| +118% | +$461K | 0.09% | 333 |
|
|
2023
Q4 | $453K | Sell |
20,884
-21,748
| -51% | -$471K | 0.05% | 440 |
|
|
2023
Q3 | $877K | Buy |
+42,632
| New | +$877K | 0.1% | 273 |
|
|
2021
Q4 | – | Sell |
-20,397
| Closed | -$904K | – | 648 |
|
|
2021
Q3 | $904K | Buy |
20,397
+7,700
| +61% | +$341K | 0.09% | 329 |
|
|
2021
Q2 | $721K | Buy |
+12,697
| New | +$721K | 0.1% | 345 |
|
|
2020
Q1 | – | Sell |
-77,074
| Closed | -$5.56M | – | 672 |
|
|
2019
Q4 | $5.56M | Buy |
+77,074
| New | +$5.56M | 0.29% | 94 |
|
|
2018
Q1 | – | Sell |
-2,180
| Closed | -$359K | – | 517 |
|
|
2017
Q4 | $359K | Buy |
+2,180
| New | +$359K | 0.04% | 364 |
|